SE9902936D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9902936D0 SE9902936D0 SE9902936A SE9902936A SE9902936D0 SE 9902936 D0 SE9902936 D0 SE 9902936D0 SE 9902936 A SE9902936 A SE 9902936A SE 9902936 A SE9902936 A SE 9902936A SE 9902936 D0 SE9902936 D0 SE 9902936D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- propylsulphonyl
- phenylethoxy
- benzothiazol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient (A) being 4-hydroxy-7-[2-[2-[3-[2-phenylethoxy]propylsulphonyl]ethylamino]ethyl]-1,3-benzothiazol-2(3<i>H</i>-one or a pharmaceutically acceptable salt thereof, and a second active ingredient (B) being a glucocorticoid, for use in the treatment of obstructive airways diseases.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902936A SE9902936D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
PCT/GB2000/003112 WO2001012191A2 (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and a glucocorticoid |
AU64601/00A AU6460100A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
ARP000104310A AR025340A1 (en) | 1999-08-18 | 2000-08-18 | PHARMACEUTICAL COMPOSITIONS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902936A SE9902936D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9902936D0 true SE9902936D0 (en) | 1999-08-18 |
Family
ID=20416694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9902936A SE9902936D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR025340A1 (en) |
AU (1) | AU6460100A (en) |
SE (1) | SE9902936D0 (en) |
WO (1) | WO2001012191A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004021959D1 (en) | 2003-11-21 | 2009-08-20 | Theravance Inc | COMPOUNDS OF AGONISTIC EFFECT ON THE BETA2 ADRENEER RECEPTOR AND THE MUSCARIN RECIPE |
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
UY31905A (en) | 2008-06-18 | 2010-01-29 | Astrazeneca Ab | DERIVATIVES OF BENZOXAZINONA, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902936A patent/SE9902936D0/en unknown
-
2000
- 2000-08-14 AU AU64601/00A patent/AU6460100A/en not_active Abandoned
- 2000-08-14 WO PCT/GB2000/003112 patent/WO2001012191A2/en active Application Filing
- 2000-08-18 AR ARP000104310A patent/AR025340A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001012191A3 (en) | 2001-09-07 |
AR025340A1 (en) | 2002-11-20 |
WO2001012191A2 (en) | 2001-02-22 |
AU6460100A (en) | 2001-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04000920A (en) | Aminoisoxazole derivatives active as kinase inhibitors. | |
GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
CA2381097A1 (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents | |
DE60228857D1 (en) | AMINO PHTALAZINONE DERIVATIVES, USE AS KINASE INHIBITORS, PREPARATION AND PHARMACEUTICAL COMPOSITION | |
CA2098302A1 (en) | Medicaments | |
CA2392879A1 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
WO2001062737A3 (en) | Amino pyrazole derivatives useful for the treatment of obesity and other disorders | |
NO20034612L (en) | 3,4-di-substituted cyclobutene-1,2-dione, pharmaceutical compositions comprising the compounds, and use of the compounds for the manufacture of medicaments for the treatment of chemokine-mediated diseases | |
WO2001098290A3 (en) | Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
BR0210122A (en) | Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same | |
HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
BR0108435A (en) | Formulation and use of low dose entecavir | |
EE04997B1 (en) | Pharmaceutical composition containing loteprednol and antihistamines, a medicament containing these agents, a process for the preparation of the medicament and use of a combination of these agents | |
HUP0104410A2 (en) | A composition for the prevention and/or treatment of atherosclerosis | |
ATE233754T1 (en) | DIPHENYL-PIPERIDINE DERIVATIVES | |
SE9902935D0 (en) | Pharmaceutical compositions | |
SE9902937D0 (en) | Pharmaceutical compositions | |
SE9902936D0 (en) | Pharmaceutical compositions | |
DE60202590D1 (en) | 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
HUP9802897A2 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
SE9903995D0 (en) | New combination | |
AU5879798A (en) | Agents inhibiting progress of pterygium and postoperative recurrence of the same | |
SE9902938D0 (en) | Pharmaceutical compositions | |
SE0001916D0 (en) | Novel formulation | |
IT1291340B1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND USE OF COLOSTRUM FOR THE TREATMENT OF ORAL CAVITY DISEASES |